Status:
UNKNOWN
Evaluation of Surgical Excision of Cardiophrenic Lymph Nodes in Patients With Advanced Ovarian Cancer
Lead Sponsor:
Mansoura University
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
20-80 years
Phase:
NA
Brief Summary
Evaluation of surgical excision of cardiophrenic lymph nodes in patients with advanced ovarian cancer
Detailed Description
The role of cardiophrenic lymph node assessment and excision in advanced ovarian cancer is still debatable , correlation of radiological finding with pathological findings after reaction of radiologic...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Ovarian cancer patient (FIGO stage III-IV)
- Preoperative CT showing CPLN with short axis diameter \> 5mm.
- Anathestically fit patient (ASA score I or II).
- Accepted pulmonary function test.
- Patient who received neoadjuvant chemotherapy or recurrent cases may be enrolled
- Written informed consent.
- Achievement of optimal cytoreduction intra-abdominal( No residual disease more than 1 cm )
- Exclusion Criteria:
- Anathestically unfit patient
- Unresectable disease
- Patient refusal
- No detected CPLN by preoperative radiology
Exclusion
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03235648
Start Date
June 1 2017
End Date
June 1 2023
Last Update
August 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology center, Mansoura University
Cairo, Dakhlia, Egypt, 35116